Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation.
Fiche publication
Date publication
janvier 2016
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Coimbra AJ, Rimola J, O'Byrne S, Lu TT, Bengtsson T, de Crespigny A, Luca D, Rutgeerts P, Bruining DH, Fidler JL, Sandborn WJ, Santillan CS, Higgins PD, Al-Hawary MM, Vermeire S, Vanbeckevoort D, Vanslembrouck R, Peyrin-Biroulet L, Laurent V, Herrmann KA, Panes J
Lien Pubmed
Résumé
Reliable tools for patient selection are critical for clinical drug trials.
Mots clés
Adult, Colon, pathology, Crohn Disease, pathology, Endoscopy, Gastrointestinal, methods, Female, Humans, Ileum, pathology, Inflammation, pathology, Magnetic Resonance Spectroscopy, methods, Male, Middle Aged, Multicenter Studies as Topic, methods, Patient Selection, Reproducibility of Results
Référence
Aliment. Pharmacol. Ther.. 2016 Jan;43(1):61-72